OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
Zaoqu Liu, Jinxiang Lv, Qin Dang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5607-5623
Open Access | Times Cited: 27
Zaoqu Liu, Jinxiang Lv, Qin Dang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5607-5623
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
CD8+ T cells in the cancer-immunity cycle
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 154
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 154
Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
Shumin Luo, Jing Chen, Fang Xu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2070-2070
Open Access | Times Cited: 32
Shumin Luo, Jing Chen, Fang Xu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2070-2070
Open Access | Times Cited: 32
Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment
Tine Logghe, Eke van Zwol, Benoît Immordino, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 505-505
Open Access | Times Cited: 10
Tine Logghe, Eke van Zwol, Benoît Immordino, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 505-505
Open Access | Times Cited: 10
Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 18
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 18
LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p/SPP1 axis as a ceRNA
Liu Ouyang, Minmin Sun, Ping-sheng Zhou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Liu Ouyang, Minmin Sun, Ping-sheng Zhou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy
Zichen Zhong, Wen Deng, Jian Wu, et al.
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8708-8738
Closed Access | Times Cited: 6
Zichen Zhong, Wen Deng, Jian Wu, et al.
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8708-8738
Closed Access | Times Cited: 6
Engineered Norovirus-Derived Nanoparticles as a Plug-and-Play Cancer Vaccine Platform
Peng Zheng, Ying Yang, Yuting Fu, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 3412-3429
Closed Access | Times Cited: 15
Peng Zheng, Ying Yang, Yuting Fu, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 3412-3429
Closed Access | Times Cited: 15
Obesity-induced thymic involution and cancer risk
Maria Lagou, George S. Karagiannis
Seminars in Cancer Biology (2023) Vol. 93, pp. 3-19
Open Access | Times Cited: 15
Maria Lagou, George S. Karagiannis
Seminars in Cancer Biology (2023) Vol. 93, pp. 3-19
Open Access | Times Cited: 15
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
Galloylated Toll-Like Receptor 7/8 Agonist Nanovaccine for Enhanced Tumor Antigen Delivery in Personalized Immunotherapy
Mengyao Ma, Ximu Li, Mingyuan Zhong, et al.
ACS Nano (2025)
Closed Access
Mengyao Ma, Ximu Li, Mingyuan Zhong, et al.
ACS Nano (2025)
Closed Access
Unravelling the modified T cell receptor through Gen-Next CAR T cell therapy in Glioblastoma: Current status and future challenges
Bhavya Bhutani, Vinay Sharma, Nirmal Kumar Ganguly, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117987-117987
Closed Access
Bhavya Bhutani, Vinay Sharma, Nirmal Kumar Ganguly, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117987-117987
Closed Access
Personalized Bacteria Loaded with Autoantigens for the Enhancement of Tumor Immunotherapy
Chenghu Wu, Wenjuan He, Yue Chen, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 11
Closed Access | Times Cited: 11
Chenghu Wu, Wenjuan He, Yue Chen, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 11
Closed Access | Times Cited: 11
Overcoming Resistance to Checkpoint Inhibitors with Combination Strategies in the Treatment of Non-Small Cell Lung Cancer
Amanda Reyes, Ramya Muddasani, Erminia Massarelli
Cancers (2024) Vol. 16, Iss. 16, pp. 2919-2919
Open Access | Times Cited: 3
Amanda Reyes, Ramya Muddasani, Erminia Massarelli
Cancers (2024) Vol. 16, Iss. 16, pp. 2919-2919
Open Access | Times Cited: 3
Peptide-Based Therapeutic HPV Cancer Vaccine Synthesized via Bacterial Outer Membrane Vesicles
Haoqian Chen, Xiao Zheng, Lingjue Li, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4541-4554
Open Access | Times Cited: 7
Haoqian Chen, Xiao Zheng, Lingjue Li, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4541-4554
Open Access | Times Cited: 7
Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
Shumin Luo, Jing Chen, Fang Xu, et al.
(2023)
Open Access | Times Cited: 6
Shumin Luo, Jing Chen, Fang Xu, et al.
(2023)
Open Access | Times Cited: 6
A personalized vaccine combining immunogenic cell death-induced cells and nanosized antigens for enhanced antitumor immunity
Ying Yang, Peng Zheng, Biao Duan, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 1271-1287
Closed Access | Times Cited: 1
Ying Yang, Peng Zheng, Biao Duan, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 1271-1287
Closed Access | Times Cited: 1
Neoantigen‐Based Nanovaccine In Combination with Immune Checkpoint Inhibitors Abolish Postsurgical Tumor Recurrence and Metastasis
Peng Zheng, Jinrong He, Zhongqian Yang, et al.
Small (2023) Vol. 19, Iss. 50
Closed Access | Times Cited: 4
Peng Zheng, Jinrong He, Zhongqian Yang, et al.
Small (2023) Vol. 19, Iss. 50
Closed Access | Times Cited: 4
Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis
Juan Zhao, Bin Liao, Li Gong, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Juan Zhao, Bin Liao, Li Gong, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
A Bibliometric Analysis of Melanoma Treated with Vaccinations Research from 2013 to 2023: A Comprehensive Review of the Literature
Xinyu Wang, Qiannan Jia, Mengyin Wu, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1113-1113
Open Access | Times Cited: 3
Xinyu Wang, Qiannan Jia, Mengyin Wu, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1113-1113
Open Access | Times Cited: 3
Long Liu, Jie Gao, Xudong Liu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 23, pp. 21531-21544
Open Access | Times Cited: 3
Advancements and hurdles in the development of a vaccine for triple-negative breast cancer: A comprehensive review of multi-omics and immunomics strategies
T Dhanushkumar, Santhosh Mukundan, Prasanna Kumar Selvam, et al.
Life Sciences (2023) Vol. 337, pp. 122360-122360
Closed Access | Times Cited: 2
T Dhanushkumar, Santhosh Mukundan, Prasanna Kumar Selvam, et al.
Life Sciences (2023) Vol. 337, pp. 122360-122360
Closed Access | Times Cited: 2
Exploring the Potential of Neoantigen-Targeted Immunotherapies in Rare Cancers
Amir Ghaffari Jolfayi, Zahra Taheri, Soroush Khojasteh-Kaffash, et al.
Springer eBooks (2024), pp. 1-32
Closed Access
Amir Ghaffari Jolfayi, Zahra Taheri, Soroush Khojasteh-Kaffash, et al.
Springer eBooks (2024), pp. 1-32
Closed Access
DeepNeoAG: Neoantigen epitope prediction from melanoma antigens using a synergistic deep learning model combining protein language models and multi-window scanning convolutional neural networks
Cheng-Che Chuang, Yuchen Liu, Yu‐Yen Ou
International Journal of Biological Macromolecules (2024), pp. 136252-136252
Closed Access
Cheng-Che Chuang, Yuchen Liu, Yu‐Yen Ou
International Journal of Biological Macromolecules (2024), pp. 136252-136252
Closed Access
Immunotherapy of Solid Tumors Based on Neoantigen Vaccines
Elahe Aleebrahim‐Dehkordi, Amir Ghaffari Jolfayi, Nima Rezaei
Springer eBooks (2024), pp. 1-19
Closed Access
Elahe Aleebrahim‐Dehkordi, Amir Ghaffari Jolfayi, Nima Rezaei
Springer eBooks (2024), pp. 1-19
Closed Access
